Biogen Pharmachem Industries Ltd — Board Meeting, 23-05-2025: Board Meeting

Biogen Pharmachem Industries Limited has announced a board meeting on which it approved the audited financial results for the year ended March 31, 2025. The company reported a net loss of Rs. 29.27 lakh for the year compared to a profit of Rs. 193.07 lakh the previous year. Total income was Rs. 83.84 lakh versus Rs. 238.15 lakh last year, with expenses rising to Rs. 113.11 lakh. Earnings per share stood at Rs. 0.00. The company’s balance sheet showed total assets of Rs. 9,201.77 lakh, largely financed by equity share capital of Rs. 6,526.03 lakh and other equity of Rs. 2,666.74 lakh. The auditor issued an unmodified opinion, confirming the financial statements present a fair view of operations. This indicates operational challenges impacting profitability and highlights the need for shareholders to monitor the company’s turnaround strategy.